| Symbol | MCET |
|---|---|
| Name | MULTICELL TECHNOLOGIES, INC. |
| Sector | UNDEFINED |
| Region | North America |
| Industry | - |
| Address | 75204 United States TX 4144 North Central Expressway Suite 600 |
| Telephone | — |
| Fax | — |
| — | |
| Website | — |
| Incorporation | US |
| Incorporated On | 1970 |
| Employees | — |
| Fiscal Year | 11/30 |
| Public Since | — |
| Exchanges | OTC |
| Auditor | Eide Bailly LLP; |
| Audit Status | NOT AVAILABLE |
| Reporting Status | Dark: Alternative Reporting Standard |
| CIK | 0000811779 |
| Description | MultiCell Technologies, Inc. is a clinical-stage biopharmaceutical company developing novel therapeutics and discovery tools that address unmet medical needs for the treatment of neurological disorders, hepatic disease, fatigue of MS and cancer. The majority owned Xenogenics subsidiary is developing a drug-eluting cardiac stent. Additional info from OTC: |
No news found.